Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.840
-0.120 (-6.10%)
Nov 21, 2024, 11:19 AM EST - Market open
Immutep Employees
Immutep had 31 employees as of June 30, 2014.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$82,687
Profits / Employee
-$919,373
Market Cap
268.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2014 | 31 | - | - |
Related Stocks
Company Name | Employees |
---|---|
OraSure Technologies | 638 |
Sage Therapeutics | 487 |
uniQure | 480 |
Vanda Pharmaceuticals | 203 |
Voyager Therapeutics | 162 |
iTeos Therapeutics | 157 |
C4 Therapeutics | 145 |
Kodiak Sciences | 111 |
IMMP News
- 5 days ago - Immutep: Potential Of Efti As New Standard Of Care For NSCLC Patients - Seeking Alpha
- 7 days ago - Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial - Benzinga
- 7 days ago - Immutep's Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer - GlobeNewsWire
- 23 days ago - Immutep Quarterly Activities Report Q1 FY25 - GlobeNewsWire
- 6 weeks ago - Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 6 weeks ago - Immutep: Navigating The Bumps In The Road - Seeking Alpha
- 2 months ago - Immutep's Efti in Combination with MSD's KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer - GlobeNewsWire
- 4 months ago - Immutep Quarterly Activities Report Q4 FY24 - GlobeNewsWire